POLR1A and cancer: Notably, when RPA194 degradation was analyzed in nontransformed human cell types, we observed either only partial degradation (IMR-90) or complete lack of RPA194 degradation (BJ fibroblasts and HEKa primary keratinocytes), overall indicative of resistance to AQ compared with cancer cells (Supplementary Fig. 7).